Analyst Kevin Caliendo works at UBS and is focused on the Healthcare sector with 313 price targets and ratings documented since 2017 spanning on 22 stocks. Previously, Kevin Caliendo worked at NEEDHAM. Analyst's average stock valuation to be materialised ratio is 75.44% with an average time for price targets to be met of 218 days.
Most recent stock forecast was given on WBA, Walgreens Boots Alliance, Inc at 07-Oct-2022.
Kevin Caliendo best performing recommendations are on TDOC (TELADOC HEALTH, INC).
The best stock recommendation documented was for ALGN (ALIGN TECHNOLOGY, INC) at 1/27/2021. The price target of $595 was fulfilled within 8 days with a profit of $85.36 (16.75%) receiving and performance score of 20.94.
Average potential price target upside